Table 3.

Crossreactivity of clones isolated by an anti-CHO mAb with other anti-CHO mAbs

Immobilized antigen	ΔA × 1000 with mAb
	SA-3	Strep 9	HGAC 39	HGAC 47	HGAC 101	SE155.4	SYAJ/6
DRPVPY-peptide	300	28	21	20	24	ND	ND
Streptavidin*	53	22	16	15	17	ND	ND
MCPPLYSPSACA	92	446	40	44	25	10	33
YPYCGHALCPGLYADAS	7	674	42	45	22	8	29
ADAAPSPTPYLPRLS	47	14	726	62	31	12	35
MCRPGIPTHHCA	6	13	44	148	29	11	33
DCGNMRQAEVCR	7	12	41	160	26	10	32
SCISAACFCI	6	12	80	120	51	12	36
KQLMAP	6	12	95	121	43	11	34
NYPMDH	6	12	58	78	37	112	36
EPYPMSEANYVRPMP	6	11	56	74	32	145	35
MDWNMH	6	16	57	69	34	13	689
MGVICMNMECDRNM	6	12	47	54	28	10	283
YTTQCGYGGCMNFE	8	14	55	55	32	12	483
f88†	7	11	48	55	26	10	34

Numbers in boldface indicate that a phage clone bearing the listed sequence was isolated by the corresponding mAb (e.g., SA-3 isolated the clone bearing the DRPVPY sequence). Underlined numbers indicate significant crossreactivity with a mAb not used to select the clone. ND, not determined. 

^*Streptavidin-coated wells used as a negative control for the DRPVPY-peptide-coated wells. 

^†Wild-type phage vector without a random peptide insert.